Physician profile
Kyle D Patch
NPI 1730669573
$649.21
in general payments reported to CMS, 2019-2025
9 companies · $27.83 in 2025
The $27.83 reported for 2025 was less than what a typical Dentist provider received nationally (typical 2025 total: $70.27).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $18.19 · 2020: $70.68 · 2021: $188 · 2022: $130 · 2023: $192 · 2024: $21.59 · 2025: $27.83.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $242.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $241.70 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Orapharma, A Division of Bausch Health US, LLC | $237.90 | 2019-2022 | |
| Align Technology, INC. | $184.00 | 2020-2025 | Invisalign, Itero Element 5d Plus, Itero Element 5d |
| Dentsply Sirona INC | $80.47 | 2023 | Suresmile, Implant Dentistry |
| Kerr Corporation | $45.77 | 2023 | Optibond Xtr |
| Nobel Biocare USA | $45.77 | 2023 | Nobelactive |
| Straumann USA LLC | $18.87 | 2021 | |
| Biohorizons Implant Systems INC. | $14.37 | 2025 | Biohorizons Dental Implants |
| Philips North America LLC | $12.07 | 2022 | |
| Ultradent Products INC | $9.99 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kyle Patch listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.